Posts by: Jose Marques Lopes, PhD

News

A recent report described a rare case of a woman presenting with a sudden decrease in voice volume who was ultimately diagnosed and successfully treated for myasthenia gravis (MG). ... Read more

March 26, 2019March 26, 2019

Soliris May Be Best Immunotherapy for MG Patients, Study Suggests

News

Soliris (eculizumab) may be the most effective and well-tolerated immunotherapy for patients with myasthenia gravis (MG), according to an analysis of multiple studies. The research, “Immunosuppressive and monoclonal antibody ... Read more

February 28, 2019February 28, 2019

Most MG Patients, Especially Men and Patients With Late-onset Disease, Respond to Plasma Exchange

News

A vast majority of patients with myasthenia gravis (MG) responded to treatment with plasma exchange and half experienced symptom relief, according to a study. The findings also showed that ... Read more

February 19, 2019February 19, 2019

Soliris Shows Sustained Efficacy and Safety for gMG in Extension Study

News

Treatment with Soliris (eculizumab) provided adults with generalized myasthenia gravis (gMG) clinically meaningful improvements through three years in daily living, muscle strength, functional ability and quality of life, according ... Read more

February 12, 2019February 12, 2019

Treatment Shows Favorable Outcomes for Patients with Juvenile Myasthenia Gravis, Study Reports

News

Treatment of juvenile myasthenia gravis (JMG) lessens the severity of symptoms in most patients, leading to stable remission without significant amounts of medication, according to a study of Polish ... Read more

January 24, 2019January 24, 2019

Flu Vaccine Safe and Effective for AChR Antibody-positive MG Patients, Study Reports

News

Patients with myasthenia gravis (MG), who are positive for the acetylcholine receptor (AChR) antibody, respond effectively to influenza vaccination, even if taking immunosuppressants. Also, influenza vaccination is safe, and ... Read more

January 10, 2019January 10, 2019

Phase 2b Trial Finds Firdapse Effective, Safe in Adults with MuSK-MG

News

Treatment of adult MuSK-antibody positive myasthenia gravis (MuSK-MG) patients with the investigational therapy Firdapse (amifampridine phosphate) improved muscle strength, eased fatigue, and was safe, according to full results of a Phase 2b ... Read more

January 8, 2019January 8, 2019

Researchers Develop New Test for Rapid, Less-costly Test to Detect Anti-AChR Antibodies in Myasthenia Gravis Patients

News

A new test offers a rapid, sensitive and inexpensive way to detect anti-acetylcholine receptor (AChR) antibodies in patients with myasthenia gravis (MG). The study with that finding, “A Simple, ... Read more

December 4, 2018December 4, 2018

Prograf Has Potential to Ease Inflammatory Immune Response in MuSK MG Patients, Study Finds

News

Prograf (tacrolimus) suppressed the proliferation and inflammatory responses of specific immune cells collected from patients with MuSK-antibody positive myasthenia gravis (MuSK-MG), a new study. These results provide early evidence ... Read more

November 27, 2018November 27, 2018

Gender Differences in MG Onset Shift After Age 40, Study Reports

News

Myasthenia gravis (MG) onset is more common in men ages 40-70 than in women in the same age range. There are also gender differences in the incidence of MG-related ... Read more

Posts by: Jose Marques Lopes, PhD

Jose Marques Lopes, PhD

MG Should Be Suspected in Patients with Voice Alterations, Case Report Says

Soliris May Be Best Immunotherapy for MG Patients, Study Suggests

Most MG Patients, Especially Men and Patients With Late-onset Disease, Respond to Plasma Exchange

Soliris Shows Sustained Efficacy and Safety for gMG in Extension Study

Treatment Shows Favorable Outcomes for Patients with Juvenile Myasthenia Gravis, Study Reports

Flu Vaccine Safe and Effective for AChR Antibody-positive MG Patients, Study Reports

Phase 2b Trial Finds Firdapse Effective, Safe in Adults with MuSK-MG

Researchers Develop New Test for Rapid, Less-costly Test to Detect Anti-AChR Antibodies in Myasthenia Gravis Patients

Prograf Has Potential to Ease Inflammatory Immune Response in MuSK MG Patients, Study Finds

Gender Differences in MG Onset Shift After Age 40, Study Reports

Pin It on Pinterest